StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
H.C. Wainwright Reiterates Buy Rating on Arcus Biosciences (RCUS)
July 23, 2026 7:11 AM
H.C. Wainwright analyst Emily Bodnar reiterated a Buy rating and $45.00 price target on Arcus Biosciences (NYSE: RCUS).The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
